Oslo University Hospital, Radiumhospitalet is one of the four campuses of Oslo University Hospital in Oslo, Norway, and is dedicated to cancer treatment. This part of the hospital is the most specialized hospital in Norway for cancer therapy and research on cancer.

During the past decade, The Norwegian Radium Hospital conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 14 clinical trials were completed, i.e. on average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Norwegian Radium Hospital" #1 sponsor was "Oslo University Hospital" with 19 trials, followed by "Hoffmann-La Roche" with 7 trials sponsored, "Nordic Society of Gynaecological Oncology - Clinical Trials Unit" with 4 trials sponsored, "Pfizer" with 4 trials sponsored and "Boehringer Ingelheim" with 4 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Norwegian Radium Hospital" #1 collaborator was "The Research Council of Norway" with 3 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Norwegian Cancer Society" with 2 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 2 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "The Norwegian Radium Hospital" are "Cancer" (4 trials), "Malignant Melanoma" (3 trials), "Neoplasm Metastasis" (3 trials), "Ovarian Cancer" (3 trials) and "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "The Norwegian Radium Hospital" in a lesser frequency.

Most popular intervention types in "The Norwegian Radium Hospital" are "Drug" (39 trials), "Radiation" (5 trials), "Procedure" (4 trials), "Other" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (4 trials), "Paclitaxel" (4 trials), "Atezolizumab" (3 trials), "Bevacizumab" (3 trials) and "Encorafenib" (3 trials). Other intervention names were less common.

The vast majority of trials in "The Norwegian Radium Hospital" are 47 trials for "All" genders and 11 trials for "Female" genders.

Currently, there are NaN active trials in "The Norwegian Radium Hospital". undefined are not yet recruiting, 10 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in The Norwegian Radium Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in The Norwegian Radium Hospital, 6 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 7 trials that are defined as “Not Applicable".